Seismic Pharmaceuticals Launches Global Phase 3 Clinical Trial for Istaroxime in Cardiogenic Shock Patients #United_States #Durham #cardiogenic_shock #Istaroxime #Seismic_Pharmaceuticals
@newsen.bsky.socialExplore
@newsen.bsky.social
@newsen.bsky.socialSeismic Pharmaceuticals Launches Global Phase 3 Clinical Trial for Istaroxime in Cardiogenic Shock Patients #United_States #Durham #cardiogenic_shock #Istaroxime #Seismic_Pharmaceuticals